Jeff Nelson
Chief Operating Officer en MILESTONE PHARMACEUTICALS INC. .
Fortuna: - $ al 31/03/2024
Perfil
Jeff Nelson is currently the Chief Operating Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Vice President-Program Management at Oncotelic Therapeutics, Inc. from 2015 to 2017, and as the Head-Clinical Operations at Axsome Therapeutics, Inc. from 2014 to 2015.
Mr. Nelson completed his undergraduate degree at Brandeis University in 2003.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Jeff Nelson
| Empresas | Cargo | Inicio |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Operating Officer | 01/06/2020 |
Antiguos cargos conocidos de Jeff Nelson.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Formación de Jeff Nelson.
| Brandeis University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Jeff Nelson
